AOD-9604 10mg Canada

Technical Specifications

Compound Name: AOD-9604
Quantity: 10mg per vial
Format: Lyophilized peptide powder
Peptide Length: 16 amino acids
Molecular Formula: C₇₈H₁₂₃N₂₃O₂₃S₂
Molecular Weight: Approximately 1815.1 g/mol
CAS Number: 221231-10-3
Research Classification: Investigational peptide – laboratory research use only

AOD-9604 10mg Canada is supplied as a lyophilized synthetic peptide intended exclusively for laboratory-based research and analytical applications. Each vial contains 10 milligrams of the peptide fragment, prepared under controlled handling and quality-verification standards appropriate for research materials.

This product is classified as an investigational research compound and is not authorized for therapeutic, diagnostic, or consumer use in Canada.

Research Overview

AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH), specifically amino acids 176–191. It has been studied in metabolic and adipose tissue research contexts as a modified fragment designed to isolate specific biological signalling properties observed in full-length growth hormone.

Research involving AOD-9604 10mg Canada typically focuses on peptide receptor interactions, lipid metabolism pathways, and adipocyte signalling mechanisms in laboratory models. The fragment was engineered to separate selected signalling activities from broader endocrine effects associated with native growth hormone.

In academic literature, AOD-9604 is described as a growth hormone fragment analogue studied in preclinical and early-stage clinical settings. Investigations have examined its interaction with metabolic pathways under controlled experimental conditions.

AOD-9604 10mg Canada is supplied strictly for research purposes. Any references to biological activity reflect investigational findings derived from laboratory or clinical study environments and do not imply approved medical application.

Mechanism Overview

AOD-9604 corresponds to the 176–191 amino acid sequence of human growth hormone. This region has been investigated for its role in metabolic signalling separate from the full-length hormone’s endocrine functions.

In laboratory models, AOD-9604 has been studied for its effects on lipid metabolic pathways, including lipolysis-related signalling cascades and the inhibition of lipogenesis in adipocyte cultures. Researchers evaluate how this peptide fragment interacts with growth hormone receptor-associated pathways without fully activating the complete hormonal axis.

Unlike intact growth hormone, AOD-9604 does not replicate the full spectrum of endocrine signalling. Its truncated structure is designed to limit interaction with receptors responsible for systemic growth effects in experimental models.

AOD-9604 10mg Canada is often examined in cell-based assays and animal studies that focus on metabolic regulatory mechanisms. Mechanistic descriptions remain confined to investigational research findings.

Clinical Development Context

AOD-9604 has undergone exploratory clinical evaluation in regulated research programmes. Early-stage studies investigated pharmacokinetics, metabolic biomarker responses, and tolerability parameters within structured study protocols.

These investigations aimed to determine whether the growth hormone fragment retained specific metabolic signalling properties independent of broader endocrine effects. Results have been reported in peer-reviewed publications and regulatory submissions.

Despite historical research, AOD-9604 is not currently authorized as a prescription medication in Canada. AOD-9604 10mg, supplied in research format, reflects the investigational compound profile described in the scientific literature.

The laboratory-grade product is categorized strictly as a research material and is not represented as an approved therapeutic agent.

Regulatory Status in Canada

Health Canada does not approve AOD-9604 as a prescription drug, natural health product, or consumer health product.

AOD-9604 10mg Canada is classified as an investigational research peptide. It is supplied exclusively for laboratory and analytical use and is not intended for human or veterinary administration.

Handling, storage, and research involving AOD-9604 10mg in Canada must comply with applicable federal and provincial Canadian regulations governing chemical and laboratory materials. Researchers and institutions are responsible for ensuring regulatory adherence.

Molecular and Structural Notes

AOD-9604 is a short synthetic peptide consisting of 16 amino acids corresponding to the 176–191 fragment of human growth hormone. Its molecular weight of approximately 1815.1 g/mol reflects its relatively small size compared to the full-length 191-amino-acid growth hormone protein.

The peptide includes two cysteine residues that form a disulphide bridge, contributing to structural stability. This configuration is consistent with the native sequence region from which it is derived.

AOD-9604 10mg Canada is typically characterized in laboratory environments using analytical methods such as high-performance liquid chromatography (HPLC) and mass spectrometry to confirm identity and purity.

The lyophilized format supports compound stability during storage when maintained under appropriate research laboratory conditions.

Frequently Asked Questions

What is AOD-9604 10mg Canada studied for in research?
AOD-9604 10mg Canada is examined in laboratory and clinical research investigating growth hormone fragment signalling and metabolic pathway modulation.

Is AOD-9604 approved for medical use in Canada?
No. Health Canada does not authorize AOD-9604 for therapeutic or consumer use.

What type of compound is AOD-9604?
It is a synthetic peptide fragment derived from the 176–191 region of human growth hormone.

Does AOD-9604 10mg Canada contain additives?
Unless specified in batch documentation, the vial contains the lyophilized peptide compound without added excipients.

Can AOD-9604 10mg Canada be used outside of research settings?
No. It is supplied strictly for laboratory and analytical research purposes.

Educational Disclaimer

AOD-9604 10mg Canada is an investigational research peptide supplied exclusively for laboratory and analytical use. Health Canada does not approve it as a medication, therapeutic agent, or consumer product.

The information provided on this page is educational and based on publicly available scientific literature describing investigational research contexts. No medical, diagnostic, or therapeutic claims are made.

Study and handling of AOD-9604 10mg Canada should occur only within properly equipped research facilities and in accordance with applicable Canadian regulations and institutional guidelines.